Mr. Speaker, as I have already observed, the Americans are going in the same direction we were talking about earlier in the week which is looking at the connection between patents and profits at a time of urgent public need.
I can tell the member there is no price mentioned in the agreement with Bayer. The fact is that I have written to the president of Bayer today to say that we expect that Canadians will get the benefit of the same reduction in price that the Americans are provided with. I fully expect that will be the case.